Mechanism of SIRT1-mediated autophagy in endometriosis

To explore the mechanism of Bushen Wenyang Huayu therapy in the treatment of endometriosis based on SIRT1-mediated autophagy

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200055200

Enrollment

Unknown

Registered

2022-01-02

Start date

2022-02-01

Completion date

Unknown

Last updated

2023-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometriosis

Interventions

endometriosis group:none

control group:none

Eligibility

Sex/Gender

Female

Age

20 Years to 49 Years

Inclusion criteria

Inclusion criteria: 1. Those who meet the diagnostic criteria and TCM syndrome differentiation criteria, voluntarily join this study, and sign the informed consent; 2. Women between the ages of 20 and 49 who are not menopausal; 3. No medical complications; 4. Not receiving hormones and other western medicines for 3 months before enrollment; 5. Endometriosis confirmed by pathological diagnosis.

Exclusion criteria

Exclusion criteria: Patients with psychiatric and neurological diseases.

Design outcomes

Primary

Measure	Time frame
silent information regulator 1;microtubule-associated protein light chain 3;P62;Beclin1;ovarian cancer epithelium antigen 125;	—

Countries

China

Contacts

Public ContactChen Jingwei

Hebei University of Chinese Medicine

chenjingwei1999@126.ccom+86 13582357697

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026